ArticleJournal of gastroenterology2022

Sorafenib as adjuvant therapy following radiofrequency ablation for recurrent hepatocellular carcinoma within Milan criteria: a multicenter analysis.

Qunfang Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.